HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 1 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
A bill to be entitled 1
An act relating to xylazine; amending s. 893.03, F.S.; 2
providing for use of xylazine as an animal drug in 3
certain circumstances; providing an effective date. 4
5
Be It Enacted by the Legislature of the State of Florida: 6
7
Section 1. Paragraph (c) of subsection (1) of section 8
893.03, Florida Statutes, is amended to read: 9
893.03 Standards and schedules. —The substances enumerated 10
in this section are controlled by this chapter. The controlled 11
substances listed or to be listed in Schedules I, II, III, IV, 12
and V are included by whatever official, common, usual, 13
chemical, trade name, or class designated. The provisions of 14
this section shall not be construed to inclu de within any of the 15
schedules contained in this section any excluded drugs listed 16
within the purview of 21 C.F.R. s. 1308.22, styled "Excluded 17
Substances"; 21 C.F.R. s. 1308.24, styled "Exempt Chemical 18
Preparations"; 21 C.F.R. s. 1308.32, styled "Exempted 19
Prescription Products"; or 21 C.F.R. s. 1308.34, styled "Exempt 20
Anabolic Steroid Products." 21
(1) SCHEDULE I.—A substance in Schedule I has a high 22
potential for abuse and has no currently accepted medical use in 23
treatment in the United States and in its u se under medical 24
supervision does not meet accepted safety standards. The 25
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 2 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
following substances are controlled in Schedule I: 26
(c) Unless specifically excepted or unless listed in 27
another schedule, any material, compound, mixture, or 28
preparation that conta ins any quantity of the following 29
hallucinogenic substances or that contains any of their salts, 30
isomers, including optical, positional, or geometric isomers, 31
homologues, nitrogen -heterocyclic analogs, esters, ethers, and 32
salts of isomers, homologues, nitr ogen-heterocyclic analogs, 33
esters, or ethers, if the existence of such salts, isomers, and 34
salts of isomers is possible within the specific chemical 35
designation or class description: 36
1. Alpha-Ethyltryptamine. 37
2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2-38
oxazoline). 39
3. Aminorex (2-Amino-5-phenyl-2-oxazoline). 40
4. DOB (4-Bromo-2,5-dimethoxyamphetamine). 41
5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 42
6. Bufotenine. 43
7. Cannabis. 44
8. Cathinone. 45
9. DET (Diethyltryptamine). 46
10. 2,5-Dimethoxyamphetamine. 47
11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine). 48
12. DMT (Dimethyltryptamine). 49
13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine 50
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 3 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
analog of phencyclidine). 51
14. JB-318 (N-Ethyl-3-piperidyl benzilate). 52
15. N-Ethylamphetamine. 53
16. Fenethylline. 54
17. 3,4-Methylenedioxy-N-hydroxyamphetamine. 55
18. Ibogaine. 56
19. LSD (Lysergic acid diethylamide). 57
20. Mescaline. 58
21. Methcathinone. 59
22. 5-Methoxy-3,4-methylenedioxyamphetamine. 60
23. PMA (4-Methoxyamphetamine). 61
24. PMMA (4-Methoxymethamphetamine). 62
25. DOM (4-Methyl-2,5-dimethoxyamphetamine). 63
26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 64
27. MDA (3,4-Methylenedioxyamphetamine). 65
28. JB-336 (N-Methyl-3-piperidyl benzilate). 66
29. N,N-Dimethylamphetamine. 67
30. Parahexyl. 68
31. Peyote. 69
32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine 70
analog of phencyclidine). 71
33. Psilocybin. 72
34. Psilocyn. 73
35. Salvia divinorum, except for any drug product approved 74
by the United States Food and Drug Administration w hich contains 75
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 4 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
Salvia divinorum or its isomers, esters, ethers, salts, and 76
salts of isomers, esters, and ethers, if the existence of such 77
isomers, esters, ethers, and salts is possible within the 78
specific chemical designation. 79
36. Salvinorin A, except for any drug product approved by 80
the United States Food and Drug Administration which contains 81
Salvinorin A or its isomers, esters, ethers, salts, and salts of 82
isomers, esters, and ethers, if the existence of such isomers, 83
esters, ethers, and salts is possibl e within the specific 84
chemical designation. 85
37. Xylazine, except for a xylazine animal drug approved 86
by the federal Food and Drug Administration when the use of the 87
drug conforms to the approved application or is permitted under 88
21 U.S.C. s. 360b(a)(4). The manufacturing, importing, 89
distribution, prescribing, or sale of xylazine for human use is 90
not subject to this exclusion . 91
38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine) 92
(Thiophene analog of phencyclidine). 93
39. 3,4,5-Trimethoxyamphetamine. 94
40. Methylone (3,4-Methylenedioxymethcathinone). 95
41. MDPV (3,4-Methylenedioxypyrovalerone). 96
42. Methylmethcathinone. 97
43. Methoxymethcathinone. 98
44. Fluoromethcathinone. 99
45. Methylethcathinone. 100
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 5 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-101
yl)phenol) and its dimethyloctyl (C8) homologue. 102
47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-103
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-104
ol]. 105
48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 106
49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 107
50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-108
naphthoyl)indole). 109
51. BZP (Benzylpiperazine). 110
52. Fluorophenylpiperazine. 111
53. Methylphenylpiperazine. 112
54. Chlorophenylpiperazine. 113
55. Methoxyphenylpiperazine. 114
56. DBZP (1,4-Dibenzylpiperazine). 115
57. TFMPP (Trifluoromethylphenylpiperazine). 116
58. MBDB (Methylbenzodioxolylbutanamine) or (3,4 -117
Methylenedioxy-N-methylbutanamine). 118
59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 119
60. 5-Hydroxy-N-methyltryptamine. 120
61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 121
62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 122
63. Methyltryptamine. 123
64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 124
65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 125
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 6 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
66. Tyramine (4-Hydroxyphenethylamine). 126
67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 127
68. DiPT (N,N-Diisopropyltryptamine). 128
69. DPT (N,N-Dipropyltryptamine). 129
70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 130
71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 131
72. DOI (4-Iodo-2,5-dimethoxyamphetamine). 132
73. DOC (4-Chloro-2,5-dimethoxyamphetamine). 133
74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 134
75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 135
76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 136
77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 137
78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 138
79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 139
80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine). 140
81. Butylone (3,4-Methylenedioxy-alpha-141
methylaminobutyrophenone). 142
82. Ethcathinone. 143
83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 144
84. Naphyrone (Naphthylpyrovalerone). 145
85. Dimethylone (3,4 -Methylenedioxy-N,N-146
dimethylcathinone). 147
86. 3,4-Methylenedioxy-N,N-diethylcathinone. 148
87. 3,4-Methylenedioxy-propiophenone. 149
88. 3,4-Methylenedioxy-alpha-bromopropiophenone. 150
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 7 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
89. 3,4-Methylenedioxy-propiophenone-2-oxime. 151
90. 3,4-Methylenedioxy-N-acetylcathinone. 152
91. 3,4-Methylenedioxy-N-acetylmethcathinone. 153
92. 3,4-Methylenedioxy-N-acetylethcathinone. 154
93. Bromomethcathinone. 155
94. Buphedrone (alpha -Methylamino-butyrophenone). 156
95. Eutylone (3,4-Methylenedioxy-alpha-157
ethylaminobutyrophenone). 158
96. Dimethylcathinone. 159
97. Dimethylmethcathinone. 160
98. Pentylone (3,4-Methylenedioxy-alpha-161
methylaminovalerophenone). 162
99. MDPPP (3,4-Methylenedioxy-alpha-163
pyrrolidinopropiophenone). 164
100. MDPBP (3,4-Methylenedioxy-alpha-165
pyrrolidinobutyrophenone). 166
101. MOPPP (Methoxy -alpha-pyrrolidinopropiophenone). 167
102. MPHP (Methyl-alpha-pyrrolidinohexanophenone). 168
103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 169
(Benocyclidine). 170
104. F-MABP (Fluoromethylaminobutyrophenone). 171
105. MeO-PBP (Methoxypyrrolidinobutyrophenone). 172
106. Et-PBP (Ethylpyrrolidinobutyrophenone). 173
107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 174
108. Me-EABP (Methylethylaminobutyrophenone). 175
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 8 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
109. Etizolam. 176
110. PPP (Pyrrolidinopropiophenone). 177
111. PBP (Pyrrolidinobutyrophenone). 178
112. PVP (Pyrrolidinovalerophenone) or 179
(Pyrrolidinopentiophenone). 180
113. MPPP (Methyl-alpha-pyrrolidinopropiophenone). 181
114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 182
115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 183
116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 184
117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 185
118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 186
119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 187
120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 188
121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-189
methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 190
122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 191
123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 192
124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 193
125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 194
126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 195
127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 196
128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 197
129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole). 198
130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-199
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-200
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 9 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
ol). 201
131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-202
methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-203
enyl] methanol). 204
132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1-205
methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-206
1,4-dione). 207
133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene). 208
134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-209
undecanamide). 210
135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-211
undecanamide). 212
136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2-213
methyloctan-2-yl)phenol). 214
137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 215
138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole). 216
139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 217
140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2-218
methoxyphenylacetyl)indole). 219
141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-220
morpholinylmethyl)pyrrolo[1,2,3 -de]-1,4-benzoxazin-6-yl]-1-221
naphthalenylmethanone). 222
142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4-223
morpholinylmethyl)pyrrolo[1,2,3 -de]-1,4-benzoxazin-6-yl]-1-224
naphthalenylmethanone). 225
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 10 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
143. Pentedrone (alpha -Methylaminovalerophenone). 226
144. Fluoroamphetamine. 227
145. Fluoromethamphetamine. 228
146. Methoxetamine. 229
147. Methiopropamine. 230
148. Methylbuphedrone (Methyl -alpha-231
methylaminobutyrophenone). 232
149. APB ((2-Aminopropyl)benzofuran). 233
150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran). 234
151. UR-144 (1-Pentyl-3-(2,2,3,3-235
tetramethylcyclopropanoyl)indole). 236
152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-237
tetramethylcyclopropanoyl)indole). 238
153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-239
tetramethylcyclopropanoyl)indole). 240
154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-241
carboxamide). 242
155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-243
iodobenzoyl)indole). 244
156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-245
carboxamide). 246
157. URB-597 ((3′-(Aminocarbonyl)[1,1′ -biphenyl]-3-yl)-247
cyclohexylcarbamate). 248
158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid, 249
cyclohexyl ester). 250
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 11 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1-251
benzoxazin-4-one). 252
160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 253
161. 2C-H (2,5-Dimethoxyphenethylamine). 254
162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 255
163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 256
164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-257
methoxybenzyl)]phenethylamine). 258
165. MDMA (3,4-Methylenedioxymethamphetamine). 259
166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 260
167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole -3-261
carboxylate). 262
168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole -3-263
carboxylate). 264
169. Fluoro AKB48 (N -Adamant-1-yl 1-265
(fluoropentyl)indazole -3-carboxamide). 266
170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-267
pentylindazole-3-carboxamide). 268
171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-269
(4-fluorobenzyl)indazole -3-carboxamide). 270
172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-271
1-pentylindazole-3-carboxamide). 272
173. Fluoro ADBICA (N -(1-Amino-3,3-dimethyl-1-oxobutan-2-273
yl)-1-(fluoropentyl)indole -3-carboxamide). 274
174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-275
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 12 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
methoxybenzyl)]phenethylamine). 276
175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-277
methoxybenzyl)]phenethylamine). 278
176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-279
(cyclohexylmethyl)indazole -3-carboxamide). 280
177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-281
carboxylate). 282
178. Fluoro-NNEI (N-Naphthalen-1-yl 1-283
(fluoropentyl)indole -3-carboxamide). 284
179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-285
(fluoropentyl)indazole -3-carboxamide). 286
180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-287
naphthoyl)indazole). 288
181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl-289
1,4,4a,8,9,10,11,12b -octahydronaphtho[3,2-c]isochromen-12-ol). 290
182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9-291
(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-292
hexahydrobenzo[c]chromen -1-ol). 293
183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9-294
(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-295
hexahydrobenzo[c]chromen -1-ol). 296
184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)-297
6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 298
diol). 299
185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6-300
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 13 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a-301
tetrahydro-6aH-benzo[c]chromen-1-ol). 302
186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl-303
6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione). 304
187. MAPB ((2-Methylaminopropyl)benzofuran). 305
188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine). 306
189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine). 307
190. Synthetic Cannabinoids. —Unless specifically excepted 308
or unless listed in another schedule or contained within a 309
pharmaceutical product approved by the United States Food and 310
Drug Administration, any material, compound, mixture, or 311
preparation that contains any quantity of a synthetic 312
cannabinoid found to be in any of the following chemical class 313
descriptions, or homologues, nitrogen -heterocyclic analogs, 314
isomers (including optical, positional, or geometric), esters, 315
ethers, salts, and salts of homologues, nitrogen -heterocyclic 316
analogs, isomers, esters, or ethers, whenever the existence of 317
such homologues, nitrogen -heterocyclic analogs, isomers, esters, 318
ethers, salts, and salts of isomers, esters, or ethers is 319
possible within the specific chemical class or designation. 320
Since nomenclature of these synthetically produced cannabinoids 321
is not internationally standardize d and may continually evolve, 322
these structures or the compounds of these structures shall be 323
included under this subparagraph, regardless of their specific 324
numerical designation of atomic positions covered, if it can be 325
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 14 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
determined through a recognized meth od of scientific testing or 326
analysis that the substance contains properties that fit within 327
one or more of the following categories: 328
a. Tetrahydrocannabinols. —Any tetrahydrocannabinols 329
naturally contained in a plant of the genus Cannabis, the 330
synthetic equivalents of the substances contained in the plant 331
or in the resinous extracts of the genus Cannabis, or synthetic 332
substances, derivatives, and their isomers with similar chemical 333
structure and pharmacological activity, including, but not 334
limited to, Delta 9 tetrahydrocannabinols and their optical 335
isomers, Delta 8 tetrahydrocannabinols and their optical 336
isomers, Delta 6a,10a tetrahydrocannabinols and their optical 337
isomers, or any compound containing a tetrahydrobenzo[c]chromene 338
structure with substitution at either or both the 3 -position or 339
9-position, with or without substitution at the 1 -position with 340
hydroxyl or alkoxy groups, including, but not limited to: 341
(I) Tetrahydrocannabinol. 342
(II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-343
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-344
ol). 345
(III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-346
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-347
ol). 348
(IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-349
(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 350
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 15 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan-351
2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene). 352
(VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan-353
2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chrome ne). 354
(VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-355
(2,3-dimethylpentan-2-yl)-6a,7,10,10a-356
tetrahydrobenzo[c]chromene). 357
(VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)-358
6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen -1-ol). 359
(IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl-360
6a,7,10,10a-tetrahydrobenzo[c]chromen -1-ol). 361
(X) Parahexyl. 362
b. Naphthoylindoles, Naphthoylindazoles, 363
Naphthoylcarbazoles, Naphthylmethylindoles, 364
Naphthylmethylindazoles, and Naphthylmethylcarbazoles. —Any 365
compound containing a naphthoylindole, naphthoylindazole, 366
naphthoylcarbazole, naphthylmethylindole, 367
naphthylmethylindazole, or naphthylmethylcarbazole structure, 368
with or without substitution on the indole, indazole, or 369
carbazole ring to any extent, whether or not substituted on the 370
naphthyl ring to any extent, including, but not limited to: 371
(I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole). 372
(II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1-373
naphthoyl)indole). 374
(III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole). 375
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 16 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole). 376
(V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole). 377
(VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole). 378
(VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole). 379
(VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole). 380
(IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole). 381
(X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole). 382
(XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole). 383
(XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole). 384
(XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole). 385
(XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1-386
naphthoyl)indole). 387
(XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole). 388
(XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole). 389
(XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1-390
naphthoyl)indole). 391
(XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-392
naphthoyl)indole). 393
(XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole). 394
(XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole). 395
(XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole). 396
(XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1-397
naphthylmethyl]indole). 398
(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1-399
naphthoyl)indole). 400
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 17 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1-401
naphthoyl)indole). 402
(XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-403
naphthoyl)indole). 404
(XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole). 405
(XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole). 406
(XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-407
naphthoyl)indole). 408
(XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole). 409
(XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole). 410
(XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1-411
naphthoyl)indole). 412
(XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1-413
naphthoyl)indole). 414
(XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1-415
naphthoyl)indole). 416
(XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1-417
naphthoyl)indole). 418
(XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1-419
naphthoyl)indole). 420
(XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole). 421
(XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1-422
naphthoyl)indazole). 423
(XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1-424
naphthoyl)indole). 425
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 18 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1-426
naphthoyl)indole). 427
(XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole). 428
(XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1-429
naphthoyl)carbazole). 430
c. Naphthoylpyrroles. —Any compound containing a 431
naphthoylpyrrole structure, with or without substitution on the 432
pyrrole ring to any extent, whether or not substituted on the 433
naphthyl ring to any extent, including, but not limited to: 434
(I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole). 435
(II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole). 436
(III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole). 437
(IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole). 438
(V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole). 439
(VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1-440
naphthoyl)pyrrole). 441
(VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1-442
naphthoyl)pyrrole). 443
(VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1-444
naphthoyl)pyrrole). 445
(IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1-446
naphthoyl)pyrrole). 447
(X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1-448
naphthoyl)pyrrole). 449
d. Naphthylmethylenindenes. —Any compound containing a 450
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 19 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
naphthylmethylenindene structure, with or without substitution 451
at the 3-position of the indene ring to any extent, whether or 452
not substituted on the naphthyl ring to any extent, including, 453
but not limited to, JWH -176 (3-Pentyl-1-454
(naphthylmethylene)indene). 455
e. Phenylacetylindoles and Phenylacetylindazol es.—Any 456
compound containing a phenylacetylindole or phenylacetylindazole 457
structure, with or without substitution on the indole or 458
indazole ring to any extent, whether or not substituted on the 459
phenyl ring to any extent, including, but not limited to: 460
(I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole). 461
(II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole). 462
(III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole). 463
(IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole). 464
(V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole). 465
(VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole). 466
(VII) Cannabipiperidiethanone. 467
(VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2-468
methoxyphenylacetyl)indole). 469
f. Cyclohexylphenols. —Any compound containing a 470
cyclohexylphenol str ucture, with or without substitution at the 471
5-position of the phenolic ring to any extent, whether or not 472
substituted on the cyclohexyl ring to any extent, including, but 473
not limited to: 474
(I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2-475
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 20 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
yl)phenol). 476
(II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8) 477
homologue). 478
(III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2-479
methyloctan-2-yl)phenol). 480
g. Benzoylindoles and Benzoylindazoles. —Any compound 481
containing a benzoylindole or benzoylindazo le structure, with or 482
without substitution on the indole or indazole ring to any 483
extent, whether or not substituted on the phenyl ring to any 484
extent, including, but not limited to: 485
(I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole). 486
(II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole). 487
(III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-488
iodo-5-nitrobenzoyl)indole). 489
(IV) Pravadoline (1 -[2-(4-Morpholinyl)ethyl]-2-methyl-3-490
(4-methoxybenzoyl)indole). 491
(V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2-492
iodobenzoyl)indole). 493
(VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole). 494
(VII) RCS-4 C4 homologue (1-Butyl-3-(4-495
methoxybenzoyl)indole). 496
(VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo-497
3-(4-methoxybenzoyl)indole). 498
h. Tetramethylcyclopropanoylindoles and 499
Tetramethylcyclopropanoylindazoles. —Any compound containing a 500
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 21 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
tetramethylcyclopropanoylindole or 501
tetramethylcyclopropanoylindazole structure, with or without 502
substitution on the indole or indazole ring to any extent, 503
whether or not substituted on the tetramethylcyclopropyl group 504
to any extent, including, but not limited to: 505
(I) UR-144 (1-Pentyl-3-(2,2,3,3-506
tetramethylcyclopropanoyl)indole). 507
(II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3-508
tetramethylcyclopropanoyl)indole). 509
(III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3-510
tetramethylcyclopropanoyl)indole). 511
(IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3-512
tetramethylcyclopropanoyl)indole). 513
(V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl] -3-(2,2,3,3-514
tetramethylcyclopropanoyl)in dole). 515
(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3-516
tetramethylcyclopropanoyl)indole). 517
(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3-518
tetramethylcyclopropanoyl)indole). 519
(VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3-520
tetramethylcyclopropanoyl)indaz ole). 521
(IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3-522
tetramethylcyclopropanoyl)indole). 523
(X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3-524
tetramethylcyclopropanoyl)indole). 525
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 22 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole 526
carboxamides, and Adamantylindazole carboxamides. —Any compound 527
containing an adamantoyl indole, adamantoyl indazole, adamantyl 528
indole carboxamide, or adamantyl indazole carboxamide structure, 529
with or without substitution on the indole or indazole ring to 530
any extent, whether or not substituted on the adamantyl ring to 531
any extent, including, but not limited to: 532
(I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide). 533
(II) Fluoro AKB48 (N -Adamant-1-yl 1-534
(fluoropentyl)indazole -3-carboxamide). 535
(III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3-536
carboxamide). 537
(IV) AM-1248 (1-(1-Methylpiperidine)methyl -3-(1-538
adamantoyl)indole). 539
(V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole). 540
(VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide). 541
(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1-542
adamantoyl)indole). 543
j. Quinolinylindolecarboxylates, 544
Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides, 545
and Quinolinylindazolecarboxamides. —Any compound containing a 546
quinolinylindole carboxylate, quinolinylindazole carboxyla te, 547
isoquinolinylindole carboxylate, isoquinolinylindazole 548
carboxylate, quinolinylindole carboxamide, quinolinylindazole 549
carboxamide, isoquinolinylindole carboxamide, or 550
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 23 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
isoquinolinylindazole carboxamide structure, with or without 551
substitution on the indol e or indazole ring to any extent, 552
whether or not substituted on the quinoline or isoquinoline ring 553
to any extent, including, but not limited to: 554
(I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate). 555
(II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole -3-556
carboxylate). 557
(III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole -3-558
carboxylate). 559
(IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3-560
carboxylate). 561
(V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate). 562
(VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole -563
3-carboxylate). 564
(VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole -565
3-carboxylate). 566
(VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide). 567
(IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole -3-568
carboxamide). 569
k. Naphthylindolecarboxylates and 570
Naphthylindazolecarboxylates. —Any compound containing a 571
naphthylindole carboxylate or naphthylindazole carboxylate 572
structure, with or without substitution on the indole or 573
indazole ring to any extent, whet her or not substituted on the 574
naphthyl ring to any extent, including, but not limited to: 575
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 24 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3-576
carboxylate). 577
(II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3-578
carboxylate). 579
(III) Fluoro SDB-005 (1-Naphthalenyl 1-580
(fluoropentyl)indazole -3-carboxylate). 581
(IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3-582
carboxylate). 583
(V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole -3-584
carboxylate). 585
l. Naphthylindole carboxamides and Naphthylindazole 586
carboxamides.—Any compound containing a naphthylindole 587
carboxamide or naphthylindazole carboxamide structure, with or 588
without substitution on the indole or indazole ring to any 589
extent, whether or not substituted on the naphthyl ring to any 590
extent, including, but n ot limited to: 591
(I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide). 592
(II) Fluoro-NNEI (N-Naphthalen-1-yl 1-593
(fluoropentyl)indole -3-carboxamide). 594
(III) Chloro-NNEI (N-Naphthalen-1-yl 1-595
(chloropentyl)indole -3-carboxamide). 596
(IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3-597
carboxamide). 598
(V) Fluoro MN-18 (N-Naphthalen-1-yl 1-599
(fluoropentyl)indazole -3-carboxamide). 600
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 25 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl 601
indazole carboxamides, Alkylcarbonyl indole carboxylates, and 602
Alkylcarbonyl indazol e carboxylates.—Any compound containing an 603
alkylcarbonyl group, including 1 -amino-3-methyl-1-oxobutan-2-yl, 604
1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3-605
phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an 606
indole carboxamide, indazole car boxamide, indole carboxylate, or 607
indazole carboxylate, with or without substitution on the indole 608
or indazole ring to any extent, whether or not substituted on 609
the alkylcarbonyl group to any extent, including, but not 610
limited to: 611
(I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-612
pentylindole-3-carboxamide). 613
(II) Fluoro ADBICA (N -(1-Amino-3,3-dimethyl-1-oxobutan-2-614
yl)-1-(fluoropentyl)indole -3-carboxamide). 615
(III) Fluoro ABICA (N -(1-Amino-3-methyl-1-oxobutan-2-yl)-616
1-(fluoropentyl)indole -3-carboxamide). 617
(IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-618
pentylindazole-3-carboxamide). 619
(V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-620
yl)-1-(fluoropentyl)indazole -3-carboxamide). 621
(VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-622
1-pentylindazole-3-carboxamide). 623
(VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-624
oxobutan-2-yl)-1-(fluoropentyl)indazole -3-carboxamide). 625
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 26 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-626
1-(4-fluorobenzyl)indazole -3-carboxamide). 627
(IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-628
yl)-1-(4-fluorobenzyl)indazole -3-carboxamide). 629
(X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-630
(cyclohexylmethyl)indazole -3-carboxamide). 631
(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-632
1-(cyclohexylmethyl)indazole -3-carboxamide). 633
(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-634
yl)-1-(cyclohexylmethyl)indazole -3-carboxamide). 635
(XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-636
pentylindazole-3-carboxamide). 637
(XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-638
1-(fluoropentyl)indazole -3-carboxamide). 639
(XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-640
fluorobenzyl)indazole -3-carboxamide). 641
(XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-642
2-yl)-1-(cyclohexylmethyl)indazole -3-carboxamide). 643
(XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-644
oxobutan-2-yl)-1-(4-fluorobenzyl)indazole -3-carboxamide). 645
(XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-646
2-yl)-1-(cyclohexylmethyl)indole -3-carboxamide). 647
(XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-648
fluoropentyl)indole-3-carboxamide). 649
(XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-650
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 27 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
fluoropentyl)indazole -3-carboxamide). 651
(XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-652
(cyclohexylmethyl)indazole-3-carboxamide). 653
(XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4-654
fluorobenzyl)indazole -3-carboxamide). 655
(XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan-656
2-yl)-1-(cyclohexylmethyl)indazole -3-carboxylate). 657
n. Cumylindolecarboxamides and Cumylindazolecarboxamides. —658
Any compound containing a N -(2-phenylpropan-2-yl) indole 659
carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide 660
structure, with or without substitution on the indole or 661
indazole ring to any extent, whether or no t substituted on the 662
phenyl ring of the cumyl group to any extent, including, but not 663
limited to: 664
(I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3-665
carboxamide). 666
(II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-667
(fluoropentyl)indole -3-carboxamide). 668
o. Other Synthetic Cannabinoids. —Any material, compound, 669
mixture, or preparation that contains any quantity of a 670
Synthetic Cannabinoid, as described in sub -subparagraphs a.-n.: 671
(I) With or without modification or replacement of a 672
carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage 673
between either two core rings, or linkage between a core ring 674
and group structure, with or without the addition of a carbon or 675
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 28 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
replacement of a carbon; 676
(II) With or without replacement of a core ring or group 677
structure, whether or not substituted on the ring or group 678
structures to any extent; and 679
(III) Is a cannabinoid receptor agonist, unless 680
specifically excepted or unless listed in another schedule or 681
contained within a pharmaceutical product approved by t he United 682
States Food and Drug Administration. 683
191. Substituted Cathinones. —Unless specifically excepted, 684
listed in another schedule, or contained within a pharmaceutical 685
product approved by the United States Food and Drug 686
Administration, any material, c ompound, mixture, or preparation, 687
including its salts, isomers, esters, or ethers, and salts of 688
isomers, esters, or ethers, whenever the existence of such salts 689
is possible within any of the following specific chemical 690
designations: 691
a. Any compound conta ining a 2-amino-1-phenyl-1-propanone 692
structure; 693
b. Any compound containing a 2 -amino-1-naphthyl-1-694
propanone structure; or 695
c. Any compound containing a 2 -amino-1-thiophenyl-1-696
propanone structure, 697
whether or not the compound is further modified: 698
(I) With or without substitution on the ring system to any 699
extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy, 700
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 29 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused 701
dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide 702
substituents; 703
(II) With or without substitution at the 3 -propanone 704
position with an alkyl substituent or removal of the methyl 705
group at the 3-propanone position; 706
(III) With or without substitution at the 2 -amino nitrogen 707
atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or 708
not further substituted in the ring system; or 709
(IV) With or without inclusion of the 2 -amino nitrogen 710
atom in a cyclic structure, including, but not limited to: 711
(A) Methcathinone. 712
(B) Ethcathinone. 713
(C) Methylone (3,4-Methylenedioxymethcathinone). 714
(D) 2,3-Methylenedioxymethcathinone. 715
(E) MDPV (3,4-Methylenedioxypyrovalerone). 716
(F) Methylmethcathinone. 717
(G) Methoxymethcathinone. 718
(H) Fluoromethcathinone. 719
(I) Methylethcathinone. 720
(J) Butylone (3,4-Methylenedioxy-alpha-721
methylaminobutyrophenone). 722
(K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone). 723
(L) BMDP (3,4-Methylenedioxy-N-benzylcathinone). 724
(M) Naphyrone (Naphthylpyrovalerone). 725
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 30 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(N) Bromomethcathinone. 726
(O) Buphedrone (alpha -Methylaminobutyrophenone). 727
(P) Eutylone (3,4-Methylenedioxy-alpha-728
ethylaminobutyrophenone). 729
(Q) Dimethylcathinone. 730
(R) Dimethylmethcathinone. 731
(S) Pentylone (3,4-Methylenedioxy-alpha-732
methylaminovalerophenone). 733
(T) Pentedrone (alpha -Methylaminovalerophenone). 734
(U) MDPPP (3,4-Methylenedioxy-alpha-735
pyrrolidinopropiophenone). 736
(V) MDPBP (3,4-Methylenedioxy-alpha-737
pyrrolidinobutyrophenone). 738
(W) MPPP (Methyl-alpha-pyrrolidinopropiophenone). 739
(X) PPP (Pyrrolidinopropiophenone). 740
(Y) PVP (Pyrrolidinovalerophenone) or 741
(Pyrrolidinopentiophenone). 742
(Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone). 743
(AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone). 744
(BB) F-MABP (Fluoromethylaminobutyrophenone). 745
(CC) Me-EABP (Methylethylaminobutyrophenone). 746
(DD) PBP (Pyrrolidinobutyrophenone). 747
(EE) MeO-PBP (Methoxypyrrolidinobutyrophenone). 748
(FF) Et-PBP (Ethylpyrrolidinobutyrophenone). 749
(GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone). 750
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 31 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(HH) Dimethylone (3,4 -Methylenedioxy-N,N-751
dimethylcathinone). 752
(II) 3,4-Methylenedioxy-N,N-diethylcathinone. 753
(JJ) 3,4-Methylenedioxy-N-acetylcathinone. 754
(KK) 3,4-Methylenedioxy-N-acetylmethcathinone. 755
(LL) 3,4-Methylenedioxy-N-acetylethcathinone. 756
(MM) Methylbuphedrone (Methyl -alpha-757
methylaminobutyrophenone). 758
(NN) Methyl-alpha-methylaminohexanophe none. 759
(OO) N-Ethyl-N-methylcathinone. 760
(PP) PHP (Pyrrolidinohexanophenone). 761
(QQ) PV8 (Pyrrolidinoheptanophenone). 762
(RR) Chloromethcathinone. 763
(SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone. 764
192. Substituted Phenethylamines. —Unless specifically 765
excepted or unless listed in another schedule, or contained 766
within a pharmaceutical product approved by the United States 767
Food and Drug Administration, any material, compound, mixture, 768
or preparation, including its salts, isomers, esters, or ethers, 769
and salts of isomers, esters, or ethers, whenever the existence 770
of such salts is possible within any of the following specific 771
chemical designations, any compound containing a phenethylamine 772
structure, without a beta -keto group, and without a benzyl group 773
attached to the amine group, whether or not the compound is 774
further modified with or without substitution on the phenyl ring 775
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 32 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
to any extent with alkyl, alkylthio, nitro, alkoxy, thio, 776
halide, fused alkylenedioxy, fused furan, fused benzofuran, 777
fused dihydrofuran, or fused tetrahydropyran substituents, 778
whether or not further substituted on a ring to any extent, with 779
or without substitution at the alpha or beta position by any 780
alkyl substituent, with or without substitution at the nitrogen 781
atom, and with or without inclusion of the 2-amino nitrogen atom 782
in a cyclic structure, including, but not limited to: 783
a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). 784
b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine). 785
c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine). 786
d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine). 787
e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine). 788
f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine). 789
g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine). 790
h. 2C-I (4-Iodo-2,5-dimethoxyphenethylam ine). 791
i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine). 792
j. 2C-H (2,5-Dimethoxyphenethylamine). 793
k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine). 794
l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine). 795
m. MDMA (3,4-Methylenedioxymethamphetamine). 796
n. MBDB (Methylbenzodioxolylbutanamine) or (3,4 -797
Methylenedioxy-N-methylbutanamine). 798
o. MDA (3,4-Methylenedioxyamphetamine). 799
p. 2,5-Dimethoxyamphetamine. 800
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 33 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
q. Fluoroamphetamine. 801
r. Fluoromethamphetamine. 802
s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine). 803
t. DOB (4-Bromo-2,5-dimethoxyamphetamine). 804
u. DOC (4-Chloro-2,5-dimethoxyamphetamine). 805
v. DOET (4-Ethyl-2,5-dimethoxyamphetamine). 806
w. DOI (4-Iodo-2,5-dimethoxyamphetamine). 807
x. DOM (4-Methyl-2,5-dimethoxyamphetamine). 808
y. PMA (4-Methoxyamphetamine). 809
z. N-Ethylamphetamine. 810
aa. 3,4-Methylenedioxy-N-hydroxyamphetamine. 811
bb. 5-Methoxy-3,4-methylenedioxyamphetamine. 812
cc. PMMA (4-Methoxymethamphetamine). 813
dd. N,N-Dimethylamphetamine. 814
ee. 3,4,5-Trimethoxyamphetamine. 815
ff. 4-APB (4-(2-Aminopropyl)benzofuran). 816
gg. 5-APB (5-(2-Aminopropyl)benzofuran). 817
hh. 6-APB (6-(2-Aminopropyl)benzofuran). 818
ii. 7-APB (7-(2-Aminopropyl)benzofuran). 819
jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran). 820
kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran). 821
ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran). 822
mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran). 823
nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran). 824
oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran). 825
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 34 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran). 826
qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran). 827
rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran). 828
ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3-829
dihydrobenzofuran), 830
831
which does not include phenethylamine, mescaline as desc ribed in 832
subparagraph 20., substituted cathinones as described in 833
subparagraph 191., N -Benzyl phenethylamine compounds as 834
described in subparagraph 193., or methamphetamine as described 835
in subparagraph (2)(c)5. 836
193. N-Benzyl Phenethylamine Compounds. —Unless 837
specifically excepted or unless listed in another schedule, or 838
contained within a pharmaceutical product approved by the United 839
States Food and Drug Administration, any material, compound, 840
mixture, or preparation, including its salts, isomers, esters, 841
or ethers, and salts of isomers, esters, or ethers, whenever the 842
existence of such salts is possible within any of the following 843
specific chemical designations, any compound containing a 844
phenethylamine structure without a beta -keto group, with 845
substitution on the nitrogen atom of the amino group with a 846
benzyl substituent, with or without substitution on the phenyl 847
or benzyl ring to any extent with alkyl, alkoxy, thio, 848
alkylthio, halide, fused alkylenedioxy, fused furan, fused 849
benzofuran, or fused tetrahydro pyran substituents, whether or 850
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 35 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
not further substituted on a ring to any extent, with or without 851
substitution at the alpha position by any alkyl substituent, 852
including, but not limited to: 853
a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2-854
methoxybenzyl)]phenethyl amine). 855
b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2-856
hydroxybenzyl)]phenethylamine). 857
c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2-858
fluorobenzyl)]phenethylamine). 859
d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3-860
methylenedioxybenzyl)]phenethylamine). 861
e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2-862
methoxybenzyl)]phenethylamine). 863
f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2-864
hydroxybenzyl)]phenethylamine). 865
g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2-866
fluorobenzyl)]phenethylamine). 867
h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3-868
methylenedioxybenzyl)]phenethylamine). 869
i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2-870
methoxybenzyl)]phenethylamine). 871
j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2-872
methoxybenzyl)]phenethylamine). 873
k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2-874
methoxybenzyl)]phenethylamine). 875
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 36 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2-876
methoxybenzyl)]phenethylamine). 877
m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2-878
hydroxybenzyl)]phenethylamine). 879
n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2-880
fluorobenzyl)]phenethylamine). 881
o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3-882
methylenedioxybenzyl)]phenethylamine). 883
p. 25H-NBOMe (2,5-Dimethoxy-[N-(2-884
methoxybenzyl)]phenethylamine). 885
q. 25H-NBOH (2,5-Dimethoxy-[N-(2-886
hydroxybenzyl)]phenethylamine). 887
r. 25H-NBF (2,5-Dimethoxy-[N-(2-888
fluorobenzyl)]phenethylamine). 889
s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2-890
methoxybenzyl)]phenethylamine), 891
892
which does not include substituted cathinones as described in 893
subparagraph 191. 894
194. Substituted Tryptamines. —Unless specifically excepted 895
or unless listed in another schedule, or contained within a 896
pharmaceutical product approved by the United States Food and 897
Drug Administration, any material, compound, mixture, or 898
preparation containing a 2 -(1H-indol-3-yl)ethanamine, for 899
example tryptamine, st ructure with or without mono - or di-900
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 37 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
substitution of the amine nitrogen with alkyl or alkenyl groups, 901
or by inclusion of the amino nitrogen atom in a cyclic 902
structure, whether or not substituted at the alpha position with 903
an alkyl group, whether or not subs tituted on the indole ring to 904
any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy 905
groups, including, but not limited to: 906
a. Alpha-Ethyltryptamine. 907
b. Bufotenine. 908
c. DET (Diethyltryptamine). 909
d. DMT (Dimethyltryptamine). 910
e. MET (N-Methyl-N-ethyltryptamine). 911
f. DALT (N,N-Diallyltryptamine). 912
g. EiPT (N-Ethyl-N-isopropyltryptamine). 913
h. MiPT (N-Methyl-N-isopropyltryptamine). 914
i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine). 915
j. 5-Hydroxy-N-methyltryptamine. 916
k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine). 917
l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine). 918
m. Methyltryptamine. 919
n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine). 920
o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine). 921
p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine). 922
q. DiPT (N,N-Diisopropyltryptamine). 923
r. DPT (N,N-Dipropyltryptamine). 924
s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine). 925
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 38 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine). 926
u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine). 927
v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine). 928
w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine). 929
x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine). 930
y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N-931
isopropyltryptamine). 932
z. Methyl-alpha-ethyltryptamine. 933
aa. Bromo-DALT (Bromo-N,N-diallyltryptamine), 934
935
which does not include tryptamine, psilocyn as described in 936
subparagraph 34., or psilocybin as described in subparagraph 33. 937
195. Substituted Phenylcyclohexylamines. —Unless 938
specifically excepted or unless listed in another schedule, or 939
contained within a pharmaceutical product approved by the United 940
States Food and Drug Administration, any material, compound, 941
mixture, or preparation containing a phenylcyclohexylamine 942
structure, with or without any substitut ion on the phenyl ring, 943
any substitution on the cyclohexyl ring, any replacement of the 944
phenyl ring with a thiophenyl or benzothiophenyl ring, with or 945
without substitution on the amine with alkyl, dialkyl, or alkoxy 946
substituents, inclusion of the nitrogen in a cyclic structure, 947
or any combination of the above, including, but not limited to: 948
a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP 949
(Benocyclidine). 950
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 39 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog 951
of phencyclidine). 952
c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine 953
analog of phencyclidine). 954
d. PCPr (Phenylcyclohexylpropylamine). 955
e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene 956
analog of phencyclidine). 957
f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)). 958
g. PCMPA (Phenylcyclohexyl(methoxypropylamine)). 959
h. Methoxetamine. 960
i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine). 961
j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine). 962
k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine). 963
l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine). 964
m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine). 965
n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine). 966
o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine). 967
p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine). 968
q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine). 969
r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine). 970
196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2-971
piperidinylidene]-benzenesulfonamide. 972
197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-973
piperidinylidene]-benzenesulfonamide. 974
198. AH-7921, 3,4-dichloro-N-[[1-975
HB 743 2024
CODING: Words stricken are deletions; words underlined are additions.
hb0743-00
Page 40 of 40
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S
(dimethylamino)cyclohexyl]methyl] -benzamide. 976
199. U47700, trans-3,4-dichloro-N-[2-977
(dimethylamino)cyclohexyl] -N-methyl-benzamide. 978
200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine, 979
dihydrochloride. 980
Section 2. This act shall take effect July 1, 2024. 981